日本新薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4516/E00931 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/11/02 | 日証協 | 374,458株 | +0.29% | 95,257株 | -49.93% | 328,316株 | +3.92% | 82,362株 | +31.3% |
2018/10/26 | 日証協 | 373,390株 | -11.37% | 190,252株 | -43.33% | 315,922株 | -20.41% | 62,730株 | +9.22% |
2018/10/19 | 日証協 | 421,287株 | +15.37% | 335,715株 | +44.47% | 396,925株 | +11.03% | 57,432株 | -51.8% |
2018/10/12 | 日証協 | 365,147株 | -13.89% | 232,380株 | -26.19% | 357,482株 | +3.8% | 119,162株 | -7.07% |
2018/10/05 | 日証協 | 424,068株 | +2.51% | 314,849株 | +105.03% | 344,405株 | -9.46% | 128,231株 | -12.45% |
2018/09/28 | 日証協 | 413,688株 | +31.81% | 153,559株 | +12.78% | 380,405株 | +3.91% | 146,460株 | +162.26% |
2018/09/21 | 日証協 | 313,862株 | -8.9% | 136,160株 | -9.49% | 366,102株 | +15.49% | 55,846株 | -38.41% |
2018/09/14 | 日証協 | 344,513株 | +18.29% | 150,443株 | -24.75% | 316,996株 | +38.43% | 90,674株 | -12.33% |
2018/09/07 | 日証協 | 291,252株 | -10.03% | 199,921株 | +118.52% | 228,996株 | +9.94% | 103,425株 | +288.82% |
2018/08/31 | 日証協 | 323,712株 | -1.24% | 91,490株 | +10.99% | 208,295株 | -4.89% | 26,600株 | +10.21% |
2018/08/24 | 日証協 | 327,773株 | -8.49% | 82,430株 | -4.06% | 218,995株 | -4.23% | 24,135株 | -3.84% |
2018/08/17 | 日証協 | 358,201株 | -6.19% | 85,922株 | -13.49% | 228,660株 | -10.07% | 25,100株 | +141.35% |
2018/08/10 | 日証協 | 381,847株 | -6.42% | 99,321株 | -47.71% | 254,271株 | -21.39% | 10,400株 | -85.27% |
2018/08/03 | 日証協 | 408,041株 | -1.12% | 189,948株 | +21.46% | 323,471株 | +26.03% | 70,600株 | -34.39% |
2018/07/27 | 日証協 | 412,662株 | -3.07% | 156,385株 | +61.23% | 256,660株 | -4.32% | 107,611株 | +1363.7% |
2018/07/20 | 日証協 | 425,720株 | 0% | 96,992株 | 0% | 268,262株 | 0% | 7,352株 | 0% |
2018/07/13 | 日証協 | 500,488株 | -24.17% | 336,565株 | -66.65% | 365,861株 | -49.71% | 178,712株 | -67.33% |
2018/07/06 | 日証協 | 660,015株 | +46.53% | 1,009,079株 | +1063.71% | 727,444株 | +86.14% | 547,042株 | +514.92% |
2018/06/29 | 日証協 | 450,416株 | -2.04% | 86,712株 | -34.01% | 390,810株 | -8.16% | 88,961株 | -29.9% |
※株式分割は考慮していませんのでご注意ください。
Page Top